bluebird bio, Inc. Banner Image

bluebird bio, Inc.

  • Ticker BLUE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
bluebird bio, Inc. Logo Image
  • 1001-5000 Employees
  • Based in Cambridge, Massachusetts
bluebird bio is pioneering gene therapy with purpose. From their Cambridge, Mass., headquarters, they’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond their labs, they’re working to positively disrupt the healthcare system to create accessMore, transparency and education so that gene therapy can become available to all those who can benefit. bluebird bio is a human company powered by human stories. They’re putting their care and expertise to work across a spectrum of disorders including cerebral adrenoleukodystrophy, sickle cell disease, β-thalassemia and multiple myeloma, using three gene therapy technologies: gene addition, cell therapy and (megaTAL-enabled) gene editing.
4.7 / 5.0 (160)

bluebird bio, Inc. reports have an aggregate usefulness score of 4.7 based on 160 reviews.

bluebird bio, Inc.

Most Recent Annual Report

bluebird bio, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

bluebird bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!